Considering the latter, it is quite surprising that little is known on the presence of NK cells within the TME, since the immunological working-mechanism of the epidermal growth factor receptor (EGFR)-targeted antibody Cetuximab, used in the treatment of HNSCC, relies on NK-cell mediated ADCC [23]. Here, EGFR is linked to head and neck squamous cell carcinoma.